Literature DB >> 11876501

The coffee components kahweol and cafestol induce gamma-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat.

Wolfgang W Huber1, Gerlinde Scharf, Walter Rossmanith, Sonja Prustomersky, Bettina Grasl-Kraupp, Barbara Peter, Robert J Turesky, Rolf Schulte-Hermann.   

Abstract

The coffee components kahweol and cafestol (K/C) were reported to be protective against mutagenic damage by heterocylic amines and aflatoxin B1 in the rat, while in humans the consumption of coffee with a high K/C content was associated with a lower rate of colon tumors. An important mechanism of this antimutagenic effect appears to be the potential of K/C to induce glutathione-S-transferase (GST) and to enhance hepatic levels of glutathione (GSH), the co-factor of GST, which is independently involved in further protective mechanisms. In the present study, we investigated mechanisms and organ specificities (liver, kidney, lung, colon) of the K/C effect on GSH levels, and particularly the role of gamma-glutamylcysteine synthetase (GCS), the rate limiting enzyme of GSH synthesis. Chows containing one of four concentrations of either a 1:1 mixture of K/C (0.012-0.122%) or of cafestol alone (0.006-0.061%) were fed to male F344 rats for 10 days. In the K/C-treated livers, a dose-dependent increase of up to 2.4-fold in the activity of GCS was observed, being statistically significant even at the lowest dose, and associated with an increase in GSH of up to three-fold. Notably, the highest dose doubled the hepatic mRNAs of the heavy and light subunits of GCS, suggesting enhanced transcription. In the extrahepatic organs, GCS activity and GSH levels were increased as well, although more moderately than in the liver. Since enhancement of GCS had also been observed as a consequence of oxidative stress, the possibility of such an involvement in the actions of K/C was examined by determining hepatic thiobarbituric acid reactive substances and the ratio of oxidized and reduced GSH. However, no evidence of oxidative stress was detected. In summary, K/C increased GSH levels apparently through the induction of the rate limiting enzyme of GSH synthesis, which may be a key factor in the chemopreventive potential of coffee components.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11876501     DOI: 10.1007/s00204-001-0295-5

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  12 in total

1.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

2.  Association Between Coffee Intake After Diagnosis of Colorectal Cancer and Reduced Mortality.

Authors:  Yang Hu; Ming Ding; Chen Yuan; Kana Wu; Stephanie A Smith-Warner; Frank B Hu; Andrew T Chan; Jeffrey A Meyerhardt; Shuji Ogino; Charles S Fuchs; Edward L Giovannucci; Mingyang Song
Journal:  Gastroenterology       Date:  2017-11-20       Impact factor: 22.682

3.  Coffee intake and risk of colorectal cancer among Chinese in Singapore: the Singapore Chinese Health Study.

Authors:  Sabrina Peterson; Jian-Min Yuan; Woon-Puay Koh; Can-Lan Sun; Renwei Wang; Robert J Turesky; Mimi C Yu
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

4.  The relationship of coffee consumption with mortality.

Authors:  Esther Lopez-Garcia; Rob M van Dam; Tricia Y Li; Fernando Rodriguez-Artalejo; Frank B Hu
Journal:  Ann Intern Med       Date:  2008-06-17       Impact factor: 25.391

5.  Coffee and caffeine consumption in relation to sex hormone-binding globulin and risk of type 2 diabetes in postmenopausal women.

Authors:  Atsushi Goto; Yiqing Song; Brian H Chen; JoAnn E Manson; Julie E Buring; Simin Liu
Journal:  Diabetes       Date:  2010-10-28       Impact factor: 9.461

6.  The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokers.

Authors:  G Y Lai; S J Weinstein; D Albanes; P R Taylor; K A McGlynn; J Virtamo; R Sinha; N D Freedman
Journal:  Br J Cancer       Date:  2013-07-23       Impact factor: 7.640

Review 7.  Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis.

Authors:  Oliver John Kennedy; Paul Roderick; Ryan Buchanan; Jonathan Andrew Fallowfield; Peter Clive Hayes; Julie Parkes
Journal:  BMJ Open       Date:  2017-05-09       Impact factor: 2.692

8.  Antitumor Effects of Freeze-Dried Robusta Coffee (Coffea canephora) Extracts on Breast Cancer Cell Lines.

Authors:  Ayelén D Nigra; Deborah de Almeida Bauer Guimarães; César G Prucca; Otniel Freitas-Silva; Anderson J Teodoro; Germán A Gil
Journal:  Oxid Med Cell Longev       Date:  2021-05-18       Impact factor: 6.543

9.  Caffeine intake decreases oxidative stress and inflammatory biomarkers in experimental liver diseases induced by thioacetamide: Biochemical and histological study.

Authors:  Mona G Amer; Nehad F Mazen; Ahmed M Mohamed
Journal:  Int J Immunopathol Pharmacol       Date:  2017-02-01       Impact factor: 3.219

10.  All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank study.

Authors:  Oliver J Kennedy; Jonathan A Fallowfield; Robin Poole; Peter C Hayes; Julie Parkes; Paul J Roderick
Journal:  BMC Public Health       Date:  2021-06-22       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.